{"id":"W4367052531","doi":"10.1186/s13046-023-02668-3","title":"Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors","year":2023,"lang":"en","type":"erratum","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Precision BioLogic (Canada)","funders":"","keywords":"Refractory (planetary science); Monoclonal antibody; Medicine; Clinical trial; Cancer research; Oncology; Antibody; Internal medicine; Immunology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005045496,0.002521871,0.003104296,0.003057036,0.002804679,0.004016289,0.003794886,0.01162463,0.04825872],"category_scores_gemma":[0.04988369,0.001739267,0.002670819,0.00192643,0.002476827,0.001907346,0.001556962,0.01491167,0.03022012],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005285106,"about_ca_system_score_gemma":0.005623451,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01283608,"about_ca_topic_score_gemma":0.01632504,"domain_scores_codex":[0.9940181,0.0009464713,0.0007782009,0.0005486707,0.003131434,0.0005772848],"domain_scores_gemma":[0.9687631,0.008960285,0.002751984,0.001642887,0.01548985,0.002391848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005924566,0.000007270399,0.00003037059,0.00009295689,0.00001408349,0.0002812543,0.000006822604,0.00003603297,0.00005485659,0.000221058,0.9964606,0.002735467],"study_design_scores_gemma":[0.0002780095,0.0000529779,0.0008165,0.000391248,0.00008933607,0.001206888,0.00003454785,0.0004000239,0.0006804816,0.001019935,0.9949808,0.00004935183],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.0001322186,0.001206898,0.0005339742,0.05293923,0.941027,0.00004977426,0.001333809,0.0004173745,0.002359573],"genre_scores_gemma":[0.01246907,0.009317725,0.006389374,0.1855681,0.5200364,0.0004470128,0.003617934,0.002110506,0.2600438],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.04825872,"threshold_uncertainty_score":0.1614415,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2061203125853942,"score_gpt":0.577063523192409,"score_spread":0.3709432106070147,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}